C5 Palsy – Etiology, Avoidance and Management Strategies

Disclosure(s):

Alpesh A. Patel, MD MBA: Aclarion Inc: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Alphatec: Consultant (Ongoing), Royalty Recipient (Ongoing); AO Spine: Grant/Research Support (Ongoing); CTL Amedica: Royalty Recipient (Ongoing); Endoluxe: Stock Shareholder (excluding mutual funds) (Ongoing); Kuros Biosciences AG: Consultant (Ongoing); NuVasive: Consultant (Ongoing), Royalty Recipient (Ongoing); nView: Consultant (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Tissue Differentiation Intelligence: Stock Shareholder (excluding mutual funds) (Ongoing)